Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
EpicentRx
AddedFeb 17, 2024
UpdatedJun 18, 2026
EpicentRx

EpicentRx

EpicentRx Inc.: A physician-led, phase 3 clinical-stage immuno-oncology company personalizing anticancer immunotherapies.

HQ
Los Angeles, CA, US
Founded
2002
Overview
Compare
Fundraising
Employees

EpicentRx Inc. is a physician-led, phase 3 clinical-stage immuno-oncology company based in San Diego, California. It focuses on developing small molecule therapies, innate immune checkpoint inhibitors, cell-based therapies, vaccines, and oncolytic viruses. The company's mission is to personalize anticancer immunotherapies and provide chemo/radioprotection for normal tissues.

EpicentRx has made significant strides in the field of immuno-oncology, with its therapies advancing to phase 3 clinical trials. The company's innovative approach and dedication to cancer treatment have positioned it as a key player in the industry, driven by actively practicing oncologists and internists.

EpicentRx - Similar Companies

BioEclipse Therapeutics logo

BioEclipse Therapeutics

bioeclipse.com

EpiVax Oncology logo

EpiVax Oncology

epivaxtx.com

Endpoint Health logo

Endpoint Health

OncoPep logo

OncoPep

oncopep.com

Nantkwest logo

Nantkwest

Epiodyne logo

Epiodyne

INmune Bio logo

INmune Bio

inmunebio.com

Eureka Therapeutics logo

Eureka Therapeutics

eurekainc.com

Adcentrx Therapeutics logo

Adcentrx Therapeutics

adcentrx.com

Checkpoint Therapeutics logo

Checkpoint Therapeutics

checkpointtx.com

Immune-Onc Therapeutics logo

Immune-Onc Therapeutics

immuneonc.com

OmniCyte logo

OmniCyte

omnicyte.com

Epirus Biopharmaceuticals logo

Epirus Biopharmaceuticals

RadioRx logo

RadioRx

radiorx.com

Epic Sciences logo

Epic Sciences

epicsciences.com

EpicentRx - Quick Facts

Who are EpicentRx's competitors?

Companies similar to EpicentRx include BioEclipse Therapeutics, EpiVax Oncology, Endpoint Health and OncoPep.

When was EpicentRx founded?

EpicentRx was founded in 2002.

Where is EpicentRx's headquarters located?

EpicentRx's headquarters is located in Los Angeles, CA, US.

When was EpicentRx's last funding round?

EpicentRx's most recent funding round was for $500k (USD) in July 2022.

How much has EpicentRx raised to-date?

As of Jul 12, 2022, EpicentRx has raised a total of $35.5M (USD).

How many employees does EpicentRx have?

EpicentRx has 18 employees as of Feb 4, 2024.

EpicentRx - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Immunotherapies
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 15 more industry codes
NAICS
  • 513200Software Publishers
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 510000Information
  • 620000Health Care and Social Assistance
  • 513000Publishing Industries
  • 541700Scientific Research and Development Services
  • 513210Software Publishers
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 7372Prepackaged Software
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research